A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma
Clinical trial NCT05336266 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05336266
- Sponsor
- Andrew Hendifar, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2025-02-19
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.